TapewireFind a company

person · Reporting owner

Flynn Sean C.

Disclosed activity across 1 company

Tapewire entity
34610
SEC CIK
0001801993

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Vericel CorpVCEL · Entity 4481Chief Legal OfficerJune 26, 2026June 30, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Vericel Corp

Report date June 26, 2026 · Filed June 30, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,647 Last balance in matching sequence After 2026-06-26 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 16,647

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Row 2 · 2026-06-26 · Sale · Disposed 15,000 · Balance 1,647

F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.25 · Expires 2029-11-04Direct55,000 Reported balance After 2026-06-26 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 55,000

F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Filing footnotes · ownership attribution and instrument terms

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 21, 2024 Filed Jun 24, 2024 22:21 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 6,772 $45.02 $304,875.44
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 4

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 487

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:21 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 6,772 $16.25 $110,045.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 3

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionStock Option (Right to Buy) · Derivative 6,754 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · derivative · entry 7

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,246

Underlying: Common Stock · 6,754 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 6,754 $45.04 $304,200.16
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 487

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 6,754 $16.25 $109,752.50
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:07 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 8,115 $45.33 $367,852.95
Disclosure

SEC source: 0001140361-24-012608 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 08, 2024 Filed Mar 15, 2024 20:05 UTC Amendment Vericel Corp VCEL · Entity 4481 SaleCommon Stock 8,115 $45.33 $367,852.95
Disclosure

SEC source: 0001140361-24-013494 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 167

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2023.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 22, 2024 Filed Feb 26, 2024 21:05 UTC Vericel Corp VCEL · Entity 4481 GrantRestricted Stock Unit · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-009492 · form4.xml · derivative · entry 2

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 22, 2025. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 21:05 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $48.31 $0.00
Disclosure

SEC source: 0001140361-24-009492 · form4.xml · derivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-02-22

F1 · derivative.exercise_date: These options shall begin vesting on February 22, 2024 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · derivative · entry 9

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share.

F5 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025.

F7 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 2,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · derivative · entry 8

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,650

Underlying: Common Stock · 2,325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share.

F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively.

F7 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 3,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · derivative · entry 7

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F8 · price: The Fair Market Value of the vested derivative securities is $49.50 per share.

F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively.

F7 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 777 $49.50 $38,461.50
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 6

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,282

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 5

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 1,032 $49.50 $51,084.00
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 4

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,309

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 2,325 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 3

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 1,441 $49.50 $71,329.50
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,016

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-009031 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
December 14, 2023 Filed Dec 15, 2023 21:07 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 106 $37.45 $3,969.70
Disclosure

SEC source: 0001140361-23-057880 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,467

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:07 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 1,432 $34.20 $48,974.40
Disclosure

SEC source: 0001140361-23-057880 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,573

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC Vericel Corp VCEL · Entity 4481 GiftCommon Stock 1,042 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053859 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,005

F1 · kind: Reflects the gift of common stock to a charitable donor advised fund.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 19, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · derivative · entry 9

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F9 · price: The Fair Market Value of the vested derivative securities is $29.82 per share.

F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025.

F8 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 19, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 832 $29.82 $24,810.24
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 4

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,176

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 19, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 3

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 18, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 2,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · derivative · entry 8

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,975

Underlying: Common Stock · 2,325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F9 · price: The Fair Market Value of the vested derivative securities is $29.82 per share.

F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.

F8 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 18, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 1,155 $29.82 $34,442.10
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,258

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 18, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 2,325 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 17, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 GrantRestricted Stock Unit · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · derivative · entry 7

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires not disclosed

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F7 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively.

F8 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 17, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (Right to Buy) · Derivative 28,125 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · derivative · entry 6

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,125

Underlying: Common Stock · 28,125 shares

Expires 2033-02-17

F5 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document
February 17, 2023 Filed Feb 23, 2023 01:51 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (Right to Buy) · Derivative 1,875 $0.00 Strike: $29.82 $0.00
Disclosure

SEC source: 0001127602-23-006580 · form4.xml · derivative · entry 5

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2033-02-17

F5 · derivative.exercise_date: These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document
September 30, 2022 Filed Feb 13, 2023 21:39 UTC Vericel Corp VCEL · Entity 4481 GrantCommon Stock 25 $19.72 $493.00
Disclosure

SEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 3

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,088

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Feb 13, 2023 21:39 UTC Vericel Corp VCEL · Entity 4481 GrantCommon Stock 403 $21.40 $8,624.20
Disclosure

SEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,063

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 31, 2022 Filed Feb 13, 2023 21:39 UTC Vericel Corp VCEL · Entity 4481 GrantCommon Stock 215 $32.49 $6,985.35
Disclosure

SEC source: 0001127602-23-004886 · form5.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,660

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 19, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionRestricted Stock Unit · Derivative 1,750 $34.90 $61,075.00
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively.

F5 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 19, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 Tax withholdingCommon Stock 869 $34.90 $30,328.10
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,445

F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 19, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 18, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (right to buy) · Derivative 2,865 $0.00 Strike: $34.90 $0.00
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 6

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,865

Underlying: Common Stock · 2,865 shares

Expires 2032-02-18

F6 · derivative.exercise_date: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document
February 18, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 GrantRestricted Stock Unit · Derivative 9,300 $0.00 $0.00
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 5

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,300

Underlying: Common Stock · 9,300 shares

Expires not disclosed

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F7 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.

F5 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
February 18, 2022 Filed Feb 22, 2022 21:08 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (right to buy) · Derivative 51,385 $0.00 Strike: $34.90 $0.00
Disclosure

SEC source: 0001593968-22-000515 · primary_01.xml · derivative · entry 4

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,385

Underlying: Common Stock · 51,385 shares

Expires 2032-02-18

F6 · derivative.exercise_date: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document
September 30, 2021 Filed Feb 15, 2022 00:33 UTC Vericel Corp VCEL · Entity 4481 GrantCommon Stock 145 $41.48 $6,014.60
Disclosure

SEC source: 0001593968-22-000467 · primary_01.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,564

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 27, 2021 Filed Aug 31, 2021 20:10 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionStock Option (right to buy) · Derivative 7,200 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001593968-21-002045 · primary_01.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 7,200 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
August 27, 2021 Filed Aug 31, 2021 20:10 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 7,200 $55.11 $396,760.32
Disclosure

SEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,419

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 27, 2021 Filed Aug 31, 2021 20:10 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 7,200 $16.25 $117,000.00
Disclosure

SEC source: 0001593968-21-002045 · primary_01.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 21, 2021 Filed Jul 23, 2021 20:04 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionStock Option (right to buy) · Derivative 2,800 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001593968-21-001869 · primary_01.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,200

Underlying: Common Stock · 2,800 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 20:04 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 2,800 $55.01 $154,028.00
Disclosure

SEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,419

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 21, 2021 Filed Jul 23, 2021 20:04 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 2,800 $16.25 $45,500.00
Disclosure

SEC source: 0001593968-21-001869 · primary_01.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001593968-21-001845 · primary_01.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 10,000 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:07 UTC Vericel Corp VCEL · Entity 4481 SaleCommon Stock 10,000 $51.18 $511,786.00
Disclosure

SEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,419

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 15, 2021 Filed Jul 16, 2021 20:07 UTC Vericel Corp VCEL · Entity 4481 Exercise / conversionCommon Stock 10,000 $16.25 $162,500.00
Disclosure

SEC source: 0001593968-21-001845 · primary_01.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
February 19, 2021 Filed Feb 22, 2021 21:10 UTC Vericel Corp VCEL · Entity 4481 GrantStock Option (right to buy) · Derivative 56,110 $0.00 Strike: $51.40 $0.00
Disclosure

SEC source: 0001593968-21-000544 · primary_01.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,110

Underlying: Common Stock · 56,110 shares

Expires 2031-02-19

F1 · derivative.exercise_date: These options shall begin vesting on February 19, 2021 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.